Ishare Nq Biotch ETF (IBB) 281.44 $IBB Biotech ETF

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ishare Nq Biotch ETF (IBB) 281.44 $IBB

Biotech ETF Industry Outlook
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 2:39PM CDT
It has been a challenging environment for the biotech industry so far; how are these ETFs expected to perform for the rest of 2016.
PBE: 40.33 (+0.17), FBT: 96.15 (+0.33), XBI: 60.34 (+0.25), BBH: 113.79 (+0.10), IBB: 281.44 (+0.55)

After Yesterday's Decline of 1.12%, iShares Nasdaq Biotechnology Index Offers Investors Better Value
Comtex SmarTrend(R) - Wed Aug 31, 12:59PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $279.70 to a high of $283.41. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $282.06 on volume of 373,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 281.44 (+0.55)

Watch for iShares Nasdaq Biotechnology Index to Potentially Rebound After Falling 1.12% Yesterday
Comtex SmarTrend(R) - Wed Aug 31, 12:57PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $279.70 to a high of $283.41. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $282.06 on volume of 373,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 281.44 (+0.55)

Healthcare ETFs Need Some Rest
editor@etftrends.com (ETF Trends) - ETF Trends - Wed Aug 31, 9:48AM CDT
It has not been a typical year for healthcare exchange traded funds such as the Vanguard Health Care ETF (NYSEArca: VHT) and the Health Care Select Sector SPDR (NYSEArca: XLV). Political posturing has been weighing on the S&P 500’s...
XBI: 60.34 (+0.25), IBB: 281.44 (+0.55), VHT: 132.97 (-0.21), XLV: 72.57 (-0.19)

10 Most Read ETF Articles of the Week (August 22-26)
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Aug 26, 5:42PM CDT
Each day, ETFtrends.com publishes news, strategy and commentary on ETFs in the realms of Commodities, Currency, Equities and Smart-Beta to name a few. Here’s a look at the 10 most read articles of the week on ETF Trends, Aug. 22-26, 2016. Click the...
HYG: 86.50 (-0.20), USO: 10.06 (-0.30), GDXS: 16.70 (-1.38), GDJS: 1.90 (-0.10), XBI: 60.34 (+0.25), BNO: 13.43 (-0.36), IBB: 281.44 (+0.55), ZBIO: 23.72 (-0.11), XLV: 72.57 (-0.19), JNK: 36.44 (-0.10), BIS: 33.83 (-0.10), DUST: 37.44 (-4.77), XLF: 24.46 (-0.10), GDX: 26.42 (+0.93), LABD: 24.11 (-0.31), VHT: 132.97 (-0.21), JDST: 29.92 (-4.86)

Biotech ETFs in Focus After Mylan's EpiPen Controversy
Sanghamitra Saha - Zacks Investment Research - Fri Aug 26, 9:27AM CDT
Mylan offers discounts to the purchase of EpiPen to cool down criticism over its steep price. How will biotech ETFs take this move?
GNRX: 24.40 (-0.14), XBI: 60.34 (+0.25), MYL: 41.92 (-0.44), IBB: 281.44 (+0.55)

Did Crooked Hillary Just Take a Bite Out of Biotech Stocks?
Greg Guenthner - Daily Reckoning - Thu Aug 25, 10:19AM CDT
This post Did Crooked Hillary Just Take a Bite Out of Biotech Stocks? appeared first on Daily Reckoning . It’s no secret that the government loves to meddle in our lives. But this time they’ve gone too far—they’ve screwed with one of our trades....
IBB: 281.44 (+0.55), MYL: 41.92 (-0.44)

Did Hillary Clinton's Tweet Cause the Sell-Off in Mylan (MYL) Stock?
Ryan McQueeney - Zacks Investment Research - Wed Aug 24, 4:29PM CDT
Shares of pharmaceutical giant Mylan Inc. (MYL) fell over 5.5% in afternoon trading Wednesday after Hillary Clinton tweeted about its price hikes of the EpiPen medication.
FBT: 96.15 (+0.33), MYL: 41.92 (-0.44), IBB: 281.44 (+0.55)

iShares Nasdaq Biotechnology Index Set to Possibly Pullback After Yesterday's Rally of 1.83%
Comtex SmarTrend(R) - Mon Aug 22, 12:10PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $291.84 to a high of $296.67. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $292.88 on volume of 729,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 281.44 (+0.55)

iShares Nasdaq Biotechnology Index Rises 1.83% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Aug 22, 12:09PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $291.84 to a high of $296.67. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $292.88 on volume of 729,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 281.44 (+0.55)

Another Endorsement for Biotech ETFs
editor@etftrends.com (ETF Trends) - ETF Trends - Tue Aug 16, 10:30AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotechnology Index, and rival biotechnology exchange traded funds, seem to have put the woes experienced earlier this year behind them and recently have been in rally...
FBT: 96.15 (+0.33), XBI: 60.34 (+0.25), IBB: 281.44 (+0.55)

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 1.12% Rise
Comtex SmarTrend(R) - Mon Aug 15, 1:08PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $292.63 to a high of $295.91. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $294.41 on volume of 506,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 281.44 (+0.55)

15 Most Read ETF Articles of the Week (August 8-12)
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Aug 12, 5:16PM CDT
Each day, ETFtrends.com publishes news, strategy and commentary on ETFs in the realms of Commodities, Currency, Equities and Smart-Beta to name a few. Here’s a look at the Top 15 Most Viewed Articles of the Week on ETF Trends, Aug. 8-12, 2016. Click...
VTI: 111.71 (+0.06), VNM: 14.91 (-0.27), SGOL: 127.80 (+0.43), EEM: 36.81 (+0.28), GLD: 125.29 (+0.51), SIVR: 18.49 (+0.22), IBB: 281.44 (+0.55), VWO: 37.53 (+0.20), IAU: 12.65 (+0.05), PEY: 15.71 (-0.04)

Calls For Biotech ETF Rally Gain Steam
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Aug 12, 9:49AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotechnology Index, is higher by 9% over the past month and that is just one sign that the once downtrodden biotechnology group is rebounding. As IBB and rival biotech...
IBB: 281.44 (+0.55)

Mexico ETF: Another Central Bank Play
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Aug 12, 9:45AM CDT
Scores of single-country exchange traded funds are being affected by central bank policies this year. Count the iShares MSCI Mexico Capped ETF (NYSEArca: EWW), the largest ETF tracking stocks in Latin America’s second-largest economy, among...
IBB: 281.44 (+0.55)

The 3-letter Time Bomb in Your Portfolio
David Stockman - Daily Reckoning - Thu Aug 11, 3:21PM CDT
This post The 3-letter Time Bomb in Your Portfolio appeared first on Daily Reckoning . David Stockman explains that there will be no mighty central bank “put” to stop the sell-off or to brake the doomsday loop of an ETF sector that is nearly...
GDP: 0.16 (-0.04), IBB: 281.44 (+0.55)

SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 1.65% Loss
Comtex SmarTrend(R) - Wed Aug 10, 12:25PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $288.28 to a high of $294.41. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $293.14 on volume of 632,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 281.44 (+0.55)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Avatar Capital Partners Secures $156M for Japan Focus

Updated Category News Views 15

A Strategic Partnership to Boost Fund II Avatar Capital Partners has nabbed $156 million for their Fund II, aiming at $300 million in Japan's living space. But the real kicker? They're now rubbing elbows with GCM Grosvenor and the Teacher Retirement System of Texas. Fancy way to say they've got some serious artillery now, with GCM Grosvenor and TRS throwing weight as...

Continue Reading
Hot Chicken Heats Up: Hattie B’s Multi-City Expansion

Updated Category News Views 49

Riding the Waves of Recognition You ever tasted success? Well, Hattie B's Hot Chicken is dishing it out by the bucketful, and they're not letting up. Hot on the heels of back-to-back accolades from the illustrious Michelin Guide, they're stretching their spicy wings even further across the Midwest, stamping down roots in Chicago and gearing up for a grand Chattanooga...

Continue Reading
Wyndham's Ambitious Ventures Aim to Redefine Hospitality

Updated Category News Views 28

Wyndham Hotels: A New Chapter Begins Cracking open a new chapter in the bustling world of hospitality, Wyndham Hotels & Resorts isn't just taking steps; it's making strides. With the launch of 'Homes & Havens' and the vigorous rollout of Dazzler Select, we're talking about a company that's morphing into a more dynamic beast, ready to snatch up opportunities across the...

Continue Reading
Nuix Names Lori Cornmesser to Head Global Partnerships

Updated Category News Views 95

Nuix Shakes Things Up with New Leadership Nuix, a notable player in the investigative analytics and intelligence software space, just leveled up its game by bringing in Lori Cornmesser as the Global Vice President, Partner Ecosystems. This ain't your average hire. Cornmesser's been around the block—over 25 years, in fact—building and leading partner ecosystems...

Continue Reading
Latch Reports Q3 2026: Software Shines Amid Losses

Updated Category News Views 21

Latch's Performance: A Crunch Between Software and Setbacks The stock ticker might say "LTCH," but lately, Latch Inc. is feeling more like "OUCH" for investors. While they're trumpeting a solid 18% boost in software revenue, the numbers tell a mixed story. Yeah, their software side is singing, but hardware and services took a nosedive, dragging total revenue down 18.9%...

Continue Reading
Big Sipz Rides RTD Wave With Vodka-Based Lyte Ade

Updated Category News Views 54

Cracking Into a New Segment Well, it looks like Big Sipz is shaking things up with their latest concoction—Lyte Ade. In the beverage world, where spiked seltzers and canned cocktails have run riot, Big Sipz is kicking open the door to the ready-to-drink (RTD) segment with a vodka twist. This isn't just any can; we're talking about a fancy 500ml resealable Tetra Pak...

Continue Reading
LiuGong Pushes Sustainability at 2026 Dealer Conference

Updated Category News Views 123

The Road to Green: LiuGong’s Ambitious Vision In a world where more heads are turning towards sustainability, LiuGong stepped up and showcased its green aspirations with flare at the 2026 Global Dealer Conference held from November 10 to 12 in Liuzhou, China. Over 2,000 attendees, ranging from dealers to customers, were in attendance to witness what seemed to be both a...

Continue Reading
SupplyHouse Expands to Atlanta: Faster Delivery Insights

Updated Category News Views 78

Revving Up in Atlanta: SupplyHouse's Bold Move Folks, this isn’t just another blip on the logistical radar. SupplyHouse, a key player in the plumbing, HVAC, and electrical supply scene, is laying down roots in Atlanta. Yeah, just outside the bustling heart of the Southeast, they’re throwing up a fulfillment center as big as a small city block—715,000 square feet to...

Continue Reading
Wastewater Treatment Market to Hit $99.56B by 2031

Updated Category News Views 126

The Changing Face of Wastewater Treatment Here's a whopper to chew on: the wastewater treatment services market ain't your grandfather's playground anymore. No sir, it's a fast-evolving arena aiming to swell to a whopping USD 99.56 billion by 2031. Now, how's that for growth? Mark my words, driven by stringent environmental regulations and thirst for clean water, this...

Continue Reading
Housing Markets Realign: Shifting Generational Burdens

Updated Category News Views 101

Riding the Generational Equity Wave Here's a kicker for you—the housing game has warped in ways that have flummoxed even the sharpest minds nodding along at economic seminars. Elder millennials back in the early 30s bracket once rode high with those mythical low mortgage rates—magic numbers scratching the underbelly of 3%, if you can believe it. But in today's...

Continue Reading

Top 5 Most Recently Viewed Articles

Progyny, Inc. Sets Stage for Q3 2024 Financial Results Release

Updated Category News Views 92

Progyny, Inc. Prepares for Its Upcoming Q3 Results Progyny, Inc. (Nasdaq: PGNY), a leading company specializing in fertility and women's health benefits, is gearing up to share its financial results for the quarter that ended on September 30, 2024. This anticipated announcement will occur after the market closes on a Tuesday in mid-November. Join the Conference Call for...

Continue Reading
Claranova's Resilience Shines Through in Latest Revenue Report

Updated Category News Views 357

Revenue Highlights for Claranova in H1 2024-2025 Claranova (Euronext Paris: FR0013426004 - CLA) showcased impressive financial results for the first half of the fiscal year 2024-2025, achieving revenues of €294 million. Despite minor fluctuations compared to the previous year, the consistency in revenue performance reflects the company's strategic resilience and...

Continue Reading
DoubleVerify Investors Urged to Consider Legal Options Now

Updated Category News Views 336

Understanding the Current Situation with DoubleVerify The team at Faruqi & Faruqi, LLP is reaching out to those affected by financial losses related to DoubleVerify Holdings, Inc. This inquiry is particularly focused on investors who may have incurred losses exceeding $75,000, encouraging them to take action and explore their legal options. The Nature of the Investigation...

Continue Reading
Wolfspeed Enhances Financial Agreement with Renesas for Growth

Updated Category News Views 129

Wolfspeed Revises Financial Agreement to Enhance Capitalizing Potential Wolfspeed, Inc. (NYSE: WOLF), a leading semiconductor manufacturer, has recently undertaken significant steps to amend its financial agreement with Renesas Electronics America Inc. This strategic decision was disclosed in a recent SEC filing and marks a pivotal moment for the company. Key Changes to...

Continue Reading
Major Deal: Performance Brokerage Facilitates Harley-Davidson Sale

Updated Category News Views 168

Performance Brokerage Services Facilitates Harley-Davidson Deal Performance Brokerage Services, a leader in dealership buy-sell activity, has successfully navigated the sale of Carolina Coast Harley-Davidson and Beach House Harley-Davidson. These dealerships have served enthusiastic motorcycle communities and are now under new ownership. Details of the Deal This...

Continue Reading